stockrow
Friday 6 November 2026
Export RGC’s income statement to Excel — free account
Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
5.12
0.15
−2.85%
Follow RGC
Alert me
Regencell Bioscience Holdings Limited (RGC) Debt to equity
Regencell Bioscience Holdings Limited's debt to equity at the end of the quarter to 30 June 2026 was 0.0×. Over the past ten years it has ranged from 0.0× (fiscal 2026) to 0.0× (fiscal 2026) — the current reading is the highest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 0.0× and in line with the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Jun 2025 | 0.0× | — |
| Jun 2024 | 0.0× | — |
| 8 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| ALVO Alvotech compare | −6.8× |
| PBH Prestige Consumer Healthcare Inc. compare | 0.0× |
| BCRX BioCryst Pharmaceuticals, Inc. compare | 0.0× |
| RGC Regencell Bioscience Holdings Limited | 0.0× |
| AMLX Amylyx Pharmaceuticals, Inc. compare | 0.0× |
| TRLV Trulieve Cannabis Corp. compare | 0.0× |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | 0.1× |
| PRGO Perrigo Company plc compare | 1.3× |
| XERS Xeris Biopharma Holdings, Inc. compare | 3.9× |
| Drug Manufacturers Specialty & Generic industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)